In the present study, we found that C1orf105 showed a trend of low expression in both heart failure and atrial fibrillation patients, which indicated that C1orf105 was involved in the development of both diseases; it may become a new therapeutic target for patients with heart failure with atrial fibrillation. This evidence concerns the gene C1orf105 and atrial fibrillation.